News about Project CASK's institutional collaborations, affiliate network, and partnerships advancing CASK gene disorder research and community support worldwide.
Project CASK has been named a collaborator in the Critical Path Institute TRxA 2026 BRIDGe program, an FDA-partnered drug development initiative. A CASK gene disorder submission has been accepted into the program, marking a meaningful step toward clinical translation for CASK-related disorders.
